自可以通过减少矩阵囊泡体介导的IL-1β释放来减少糖尿病小鼠的大动脉化

Xiaolei Sun1, Yang Zheng2, Linzhuo Xie3

  • 1Department of General Surgery (Vascular Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China; Department of Interventional Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China; Laboratory of Nucleic Acids in Medicine for National High-Level Talents, Nucleic Acid Medicine of Luzhou Key Laboratory, Southwest Medical University, Luzhou, 646000, China; Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, 646000, China; Cardiovascular and Metabolic Diseases Key Laboratory of Sichuan, Luzhou, 646000, China.

Experimental cell research
|September 29, 2023
PubMed
概括

携带IL-1β的矩阵囊体 (MVBs) 有助于2型糖尿病的血管化. 自可以抵消这一过程,这表明MVB介导的IL-1β释放是血管化的潜在治疗标.

相关概念视频